Background Adherence to treatment is important in chronic dermatological diseases. There
are limited data regarding the adherence to treatment in patients with psoriasis during the …

Background Since psoriasis is a chronic disease, it is not recommended to discontinue the
treatment agents used. However, in real life, the treatment of psoriasis patients may be …

Abstract Background Since March 2020, the coronavirus disease 2019 (COVID‐19)
pandemic has been ongoing all around the world with a wide range of clinical course …

To the Editor, Coronavirus disease 2019 (COVID-19) affected patients' hospital admission
rates and treatment adherence since the beginning of the pandemic. 1 This retrospective …

Background Psoriasis is a chronic skin disease that needs continuous medical care. During
COVID‐19, delivering medical service was negatively affected. Aims To describe the impact …

Purpose The COVID-19 epidemic has caused difficulties in continuous treatment for patients
with chronic diseases and resulted in nonadherence to treatment and adverse health …

Background The COVID-19 pandemic introduced new challenges in several dimensions in
healthcare services. Herein, we describe the real-life strategies and therapeutic options …

Background In late 2019 a viral pneumonia began to spread across the world. The viral
disease, COVID-19, is now officially a pandemic, causing concern for the potential risk of …

We have read with great interest the articles by Bardazzi et al.(1) and Conforti et al.(2)
discussing whether it is advisable or not to stop biologic treatment in psoriasis patients …

The impact of the COVID‐19 pandemic on biologic treatment for psoriasis in Japan remains
to be elucidated. This study aimed to investigate changes in biologic treatment and patients' …